mHealth Intelligence February 14, 2018
Eric Wicklund

The FDA has approved an mHealth app that uses artificial intelligence software to analyze CT scans for signs of a stroke, then sends a text message to a neurologist. The clinical decision support tool could help speed up time to treatment for stroke victims.

Federal regulators have approved an mHealth app that uses artificial intelligence to analyze CT images for signs of a stroke, potentially speeding up the time to treatment.

The U.S. Food and Drug Administration has cleared for marketing the Contact app from Viz.AI, a San Francisco-bases startup that bills its mobile health tool as a direct-to-intervention system. The app uses computer-aided triage software to search for large vessel occlusions in brain CTs, then sends a text message...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Apps, FDA, mHealth
Certainty vs. speed: How do patients feel about the tradeoff for new cancer drugs?
FDA approves 1st monotherapy drug for treatment-resistant depression
FDA's AI Lifecycle & Scientific Information Guidance Documents
STAT+: Trump administration freezes many health agency reports and posts
Opinion: Three former FDA officials: Here’s what Trump and his nominees need to know

Share This Article